Cet anticorps anti-DEPDC1B Polyclonal Lapin (ABIN6992160) détecte spécifiquement DEPDC1B dans WB, ELISA et IHC (p).
L’anticorps est réactif avec des échantillons de Humain.
Aperçu rapide pour DEPDC1B anticorps (C-Term) (ABIN6992160)
Antigène
DEPDC1B
(DEP Domain Containing 1B (DEPDC1B))
Reactivité
Humain
Hôte
Lapin
Clonalité
Polyclonal
Conjugué
Cet anticorp DEPDC1B est non-conjugé
Application
Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Épitope
C-Term
Specificité
DEPDC1B antibody is human specific. At least two isoforms are known to exist, this antibody will only detect the largest isoform. DEPDC1B antibody is predicted to not cross-react with DEPDC1A.
Purification
DEPDC1B antibody is affinity chromatography purified via peptide column.
Immunogène
DEPDC1B antibody was raised against a 19 amino acid peptide near the carboxy terminus of human DEPDC1B. The immunogen is located within the last 50 amino acids of DEPDC1B.
DEPDC1B antibody can be used for detection of DEPDC1B by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL.
Antibody validated: Western Blot in human samples and Immunohistochemistry in human samples. All other applications and species not yet tested.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
DEPDC1B antibody is supplied in PBS containing 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C,4 °C
Stockage commentaire
DEPDC1B antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Antigène
DEPDC1B
(DEP Domain Containing 1B (DEPDC1B))
Autre désignation
DEPDC1B
Sujet
The DEP domain-containing 1B (DEPDC1B) protein was initially identified as a radiation response biomarker in human lymphoblastoid cell lines (1). Like the related protein DEPDC1A, expression of DEPDC1B correlates with a poor prognosis in cancer patients (2,3). Studies have shown that DEPDC1B levels are upregulated in non-small cell lung cancer (NSCLC) and have an inverse correlation with patient survival. Ectopic expression of DEPDC1B in NSCLC activated Wnt/B-catenin signaling and enhanced cell migration and invasion while silencing DEPDC1B expression suppressed these traits (2).